Titan Biotech Ltd — Results, 13-08-2025: Result

The board has approved the financial results for the quarter ended June 30, with consolidated profit for the period at Rs. 6.86 Cr. Additionally, Mr. Debendra Kumar Sabat has been appointed as an Additional Independent Director, bringing legal and financial expertise to the board. Mr. Naresh Kumar Singla and Mr. Suresh Chand Singla have been re-appointed as Managing Directors, ensuring leadership continuity, subject to shareholder nod. The company also announced a final dividend of Rs. 2.00 per share, with the record date set for voting eligibility at the upcoming virtual Annual General Meeting.